Clinical Evaluations and the EU Market
February 21, 2024
Artificial intelligence is everywhere right now. For medical device and regulated product teams, the real challenge is not whether AI is coming. It is understanding where it actually adds value, where it creates risk, and how to adopt it responsibly.
In this on demand webinar, Mark Cox,President of AlvaMed, shares practical lessons from AlvaMed’s 18 month journey applying AI inside highly regulated environments. This is not a theoretical discussion or a sales pitch for tools. It is a candid walkthrough of what works, what does not, and how regulatory, quality, and clinical teams can begin using AI today without compromising compliance or judgment.
If you are navigating AI adoption in medtech, quality, regulatory, or clinical functions, this session is designed to help you move forward with clarity and confidence.
click for a preview video
Mark has more than 30 years of experience supporting medical device companies across North America and Europe. He has led quality system development across pharma, devices, biologics, IVDs, cosmetics, and food products, and has deep experience in regulatory strategy, due diligence, and technology transfer.
Register to access the full recording and learn how to apply AI thoughtfully, securely, and effectively in regulated environments.
